Regulated by factors including prolactin and progesterone, RANKL could drive the primary mitogenic response of mammary epithelium and the expansion of mammary stem cells via RANK activation [22]–[24], which may therefore induce mammary cancer by offering a more transformation-susceptible target pool. The gene discussed is TNFSF11; the disease is breast cancer.